Reperfusion therapies for acute ischemic stroke: An update

Current Cardiology Reviews

Volumn 10, Issue 4, 2014, Pages 327-335

  Dorado, Laura ^a   Millán, Mònica ^a   Dávalos, Antoni ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Endovascular treatment; Ischemic stroke; Mechanical thrombectomy; Stent retriever; Thrombolysis; tPA

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; HEPARIN; TENECTEPLASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ARTICLE; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL (TOPIC); HUMAN; MECHANICAL THROMBECTOMY; NEUROIMAGING; PATIENT SELECTION; PRIORITY JOURNAL; REPERFUSION; REVASCULARIZATION; THROMBECTOMY DEVICE;

BRAIN ISCHEMIA; CLINICAL TRIALS AS TOPIC; EQUIPMENT DESIGN; FIBRINOLYTIC AGENTS; HUMANS; REPERFUSION; STENTS; STROKE; THROMBECTOMY; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84904722998     PISSN: 1573403X     EISSN: 18756557     Source Type: Journal    
DOI: 10.2174/1573403X10666140320144637     Document Type: Article

References (76)

1. Rosamond W, Flegal K, Furie K, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 117: e25-146.
2. Jauch EC, Saver JL, Adams HP Jr, et al. American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Peripheral Vascular Disease; Council on Clinical Cardiology. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013; 44: 870-947.
3. Cocho D, Belvís R, Martí-Fábregas J, et al. Reasons for exclusion for thrombolytic therapy following acute ischemic stroke. Neurology 2005; 22: 719-20.
4. Alexandrov AV, Molina CA, Grotta JC, et al. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 2004; 351: 2170-8.
5. Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke 2007; 38: 967-73.
6. Wunderlich MT, Goertler M, Postert T, et al. Recanalization after intravenous thrombolysis: does a recanalization time window exist?. Neurology 2007; 68: 1364-8.
7. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-7.
8. Hacke W, Donnan G, Fieschi C, et al. ATLANTIS Trials Investigators; ECASS Trials Investigators; NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004; 363: 768-74.
9. Khatri P, Abruzzo T, Yeatts SD, et al. for the IMS I and II Investigators. Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology 2009; 73: 1066-72.
10. Gasparotti R, Grassi M, Marghindian D, et al. Perfusion CT in patients with acute ischemic stroke treated with intra-arterial thrombolysis: predictive value of infarct core size on clinical outcome. AJNR 2009; 30: 722-7.
11. Mishra NK, Albers GW, Davis SM, et al. Mismatch-based delayed thrombolysis: a meta-analysis. Stroke 2010; 41: e25-33.
12. Wahlgren N, Ahmed N, Davalos A, et al, SITS-MOST investigators. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007; 369: 275-82.
13. Hacke W, Kaste M, Bluhmki E, et al, ECASS Investigators. Thrombolysis with alteplase 3 to 4. 5 hours after acute ischemic stroke. N Engl J Med 2008; 359: 1317-29.
14. Wahlgren N, Ahmed N, Dávalos A, et al, SITS investigators. Thrombolysis with alteplase 3-4. 5 hours after acute ischemic stroke (SITS-ISTR): an observational study. Lancet 2008; 372: 1303-9.
15. Lees KR, Bluhmki E, von Kummer R, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010; 375: 1695-703.
16. Ford GA, Ahmed N, Azevedo E, et al. Intravenous alteplase for stroke in those older than 80 years old. Stroke 2010; 41: 2568-74.
17. Mishra NK, Diener HC, Lyden PD, et al, VISTA Collaborators. Influence of age on outcome from thrombolysis in acute stroke: a controlled comparison in patients from the Virtual International Stroke Trials Archive (VISTA). Stroke 2010; 41: 2840-8.
18. Mishra NK, Ahmed N, Andersen G, et al, VISTA collaborators; SITS collaborators. Thrombolysis in very elderly people: controlled comparison of SITS International Stroke Thrombolysis Registry and Virtual International Stroke Trials Archive. BMJ 2010; 341: c6046.
19. IST-3 collaborative group, Sandercock P, Wardlaw JM, Lindley RI, et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet 2012; 379: 2352-63.
20. Ahmed N, Dávalos A, Eriksson N, et al, SITS Investigators. Association of admission blood glucose and outcome in patients treated with intravenous thrombolysis: results from the Safe Implementation of Treatments in Stroke International Stroke Thrombolysis Register (SITS-ISTR). Arch Neurol 2010; 67: 1123-30.
21. Mishra NK, Ahmed N, Davalos A, et al, SITS and VISTA collaborators. Thrombolysis outcomes in acute ischemic stroke patients with prior stroke and diabetes mellitus. Neurology 2011; 77: 1866-72.
22. Kidwell CS, Alger JR, Saver JL. Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke 2003; 34: 2729-35.
23. Donnan GA, Baron JC, Ma H, et al. Penumbral selection of patients for trials of acute stroke therapy. Lancet Neurol 2009; 8: 261-9.
24. Röther J, Shellinger PD, Gass A, et al. Effect of intravenous thrombolysis on MRI parameters and functional outcome in acute stroke < 6 hours. Stroke 2002; 36: 1452-6.
25. Ribó M, Molina CA, Rovira A, et al. Safety and efficacy of intravenous tissue plasminogen activator stroke treatment in the 3-to 6-hour window using multimodal transcraneal Doppler/MRI selection protocol. Stroke 2005; 36: 602-6.
26. Schellinger PD, Thomalla G, Fiehler J, et al. MRI-based and CTbased thrombolytic therapy in acute stroke within and beyond established time windows: an analysis of 1210 patients. Stroke 2007; 38: 2640-5.
27. Copen WA, Rezai Gharai L, Barak ER, et al. Existence of the diffusion-perfusion mismatch within 24 hours after onset of acute stroke: dependence on proximal arterial occlusion. Radiology 2009; 250: 878-86.
28. Obach V, Oleaga L, Urra X, et al. Multimodal CT-assisted thrombolysis in patients with acute stroke: a cohort study. Stroke 2011; 42: 1129-31.
29. Albers GW, Thijs VN, Wechsler L, et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006; 60: 508-17.
30. Davis SM, Donnan GA, Parsons MW, et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008; 7: 299-309.
31. Hacke W, Albers G, Al-Rawi Y, et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005; 36: 66-73.
32. Furlan AJ, Eyding D, Albers GW, et al. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 2006; 37: 1227-31.
33. Hacke W, Furlan AJ, Al-Rawi Y, et al. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusiondiffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol 2009; 8: 141-50.
34. Olivot JM, Mlynash M, Thijs VN, et al. Relationships between infarct growth, clinical outcome, and early recanalization in diffusion and perfusion imaging for understanding stroke evolution (DEFUSE). Stroke 2008; 39: 2257-63.
35. Wang Y, Liao X, Zhao X, et al. Imaging-based thrombolysis trial in acute ischemic stroke-II (ITAIS-II). Int J Stroke 2009; 4: 49-53.
36. Haley EC Jr, Thompson JL, Grotta JC, et al. Tenecteplase in Stroke Investigators. Phase IIB/III trial of tenecteplase in acute ischemic stroke: results of a prematurely terminated randomized clinical trial. Stroke 2010; 41: 707-11.
37. Smadja D, Chausson N, Joux J, et al. A new therapeutic strategy for acute ischemic stroke: sequential combined intravenous tPAtenecteplase for proximal middle cerebral artery occlusion based on first results in 13 consecutive patients. Stroke 2011; 42: 1644-7.
38. Parsons M, Spratt N, Bivard A, et al. A randomized trial of tenecteplase versus alteplase for acute ischemic stroke. N Engl J Med 2012; 366: 1099-107.
39. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial Prourokinase for Acute Ischemic Stroke. The PROACT II Study: A Randomized Controlled Trial. JAMA 1999; 282: 2003-11.
40. Ogawa A, Mori E, Minematsu K, et al. Randomized Trial of Intraarterial Infussion of Urokinase Within 6 Hours of Middle Cerebral Artery Stroke. The Middle Cerebral Artery Embolism Local Fibrinolytic Intervention Trial (MELT) Japan. Stroke 2007; 38: 2633-9.
41. Lee M, Hong KS, Saver JL. Efficacy of intra-arterial frbrinolysis for acute ischemic stroke: meta-analysis of randomized controlled trials. Stroke 2010; 41: 932-7.
42. Lewandowski CA, Frankel M, Tomsick TA, et al. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 1999; 30: 2598-605.
43. The IMS study investigators. Combined intravenous and intraarterial recanalization for acute ischemic stroke: The interventional management of stroke study. Stroke 2004; 35: 904-12.
44. The IMS study investigators. The interventional management of stroke (IMS) II study. Stroke 2007; 38: 2127-35.
45. Rubiera M, Ribo M, Pagola J, et al. Bridging intravenousintraarterial rescue strategy increases recanalization and the likelihood of a good outcome in nonresponder intravenous tissue plasminógeno activator-treated patients: a case-control study. Stroke 2011; 42: 993-7.
46. Gobin YP, Starkman S, Duckwiler GR, et al. MERCI 1: a phase 1 study of Mechanical Embolus Removal in Cerebral Ischemia. Stroke 2004; 35: 2848-54.
47. Smith WS, Sung G, Starkman S, for the MERCI Trial Investigators. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005; 36: 1432-8.
48. Smith WS, Sung G, Saver J, for the Multi MERCI Investigators. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008; 39: 1205-12.
49. Nogueira RG, Liebeskind DS, Sung G, et al, on behalf of the MERCI and MultiMERCI writing Committee. Predictors of good clinical outcomes, mortality, and successful revascularization in patients with acute ischemic stroke undergoing thrombectomy. Pooled analysis of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and MultiMERCI Trials. Stroke 2009; 40: 3777-83.
50. Fields JD, Lutsep HL, Smith WS, MERCI and MultiMERCI Investigators. Higher degrees of recanalization after mechanical thrombectomy for acute stroke are associated with improved outcome and decreased mortality: pooled analysis of the MERCI and MultiMERCI trials. AJNR 2011; 32: 2170-4.
51. Shi ZS, Loh Y, Walker G, et al, for the MERCI and MultiMERCI Investigators. Endovascular thrombectomy for acute ischemic stroke in failed intravenous tissue plasminogen activator versus non-intravenous tissue plasminogen activator patients. Revascularization and outcomes stratified by the site of arterial occlusion. Stroke 2010; 41: 1185-92.
52. Nogueira RG, Smith WS, Sung G, et al, on behalf of the MERCI and MultiMERCI Writing Committee. Effect of time to reperfusion on clinical outcome of anterior circulation strokes treated with thrombectomy. Pooled analysis of the MERCI and MultiMERCI Trials. Stroke 2011; 42: 3144-9.
53. Bose A, Henkes H, Alfke K, for the Penumbra Phase 1 Stroke Trial Investigators. The Penumbra System: a mechanical device for the treatment of acute stroke due to thromboembolism. AJNR2008; 29: 1409-13.
54. Penumbra Pivotal Stroke Trial Investigators. The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009; 40: 2761-8.
55. Tarr R, Hsu D, Kulcsar Z, Bonvin C, et al. The POST trial: initial post-market experience of the Penumbra system: revascularization of large vessel occlusion in acute ischemic stroke in the United Stated and Europe. J Neurointerv Surg 2010; 2: 341-4.
56. Stead LG, Rachel M, Gilmore M, et al. Percutaneous clot removal devices in acute ischemic stroke. A systemic review and metaanalysis. Arch Neurol 2008; 65: 1024-30.
57. Jankowitz B, Aghaebrahim A, Zirra A, et al. Manual aspiration thrombectomy. Adjunctive endovascular recanalization technique in acute stroke interventions. Stroke 2012; 43: 1408-11.
58. Chimowitz MI, Lunn MJ, Derdeyn CP, et al, SAMMPRIS Trial Investigators. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Eng J Med 2011; 365: 993-1003.
59. Castaño C, Dorado L, Guerrero C, et al. Mechanical thrombectomy with the Solitaire AB device in large artery occlusions of the anterior circulation: a pilot study. Stroke 2010; 41: 1836-40.
60. Roth C, Papanagiotou P, Behnke S, et al. Stent-assisted mechanical recanalization for treatment of acute intracerebral artery occlusions. Stroke 2010; 41: 2559-67.
61. Miteff F, Faulder KC, Goh AC, et al. Mechanical thrombectomy with a self-expanding retrievable intracranial stent (Solitaire AB): experience in 26 patients with acute cerebral artery occlusions. AJNR 2011; 32: 1078-81.
62. Costalat V, Machi P, Lobotesis K, et al. Rescue, combined and stand-alone thrombectomy in the management of large vessel occlusion stroke using the solitaire device; a prospective 50-patients single-center study: timing, safety and efficacy. Stroke 2011; 42: 1929-35.
63. Mendonça N, Flores A, Pagola J, et al. Trevo System: Singlecenter experience with a novel mechanical thrombectomy device. J Neuroimaging 2013; 23: 7-11.
64. San Román L, Obach V, Blasco J, et al. Single-center experience of cerebral artery thrombectomy using the Trevo device in 60 patients with acute ischemic stroke. Stroke 2012; 43: 1657-9.
65. Rohde S, Haehnel S, Herweh C, et al. Mechanical thrombectomy in acute embolic stroke. Preliminary results with the Revive device. Stroke 2011; 42: 2954-6.
66. Dávalos A, Pereira VM, Chapot R, et al, by the Solitaire Group. Retrospective Multicenter Study of Solitaire FR for Revascularization in the Treatment of Acute Ischemic Stroke. Stroke. 2012; 43: 2699-705.
67. Pereira VM, Gralla J, Davalos A, et al. Prospective, multicenter, single-arm study of mechanical thrombectomy using Solitaire Flow Restoration in acute ischemic stroke. Stroke. 2013; 44: 2802-7.
68. Saver JL, Jahan R, Levy EI, et al, for the SWIFT Trialists. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non inferiority trial. Lancet 2012; 380: 1241-9.
69. Nogueira RG, Lutsep HL, Gupta R, et al, for the TREVO 2 Trialists. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet 2012; 380: 1231-40.
70. Broderick JP, Palesch YY, Demchuk AM, et al, Interventional Management of Stroke (IMS) III Investigators. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 2013; 368: 893-903.
71. Ciccone A, Valvassori L, Nichelatti M, et al, SYNTHESIS Expansion Investigators. Endovascular treatment for acute ischemic stroke. N Engl J Med 2013; 368: 904-13.
72. Kidwell CS, Jahan R, Gornbein J, et al, MR RESCUE Investigators. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med. 2013; 368: 914-23.
73. Parsons MW, Albers GW. MR RESCUE: is the glass half-full or half-empty? Stroke 2013; 44: 2055-7.
74. Nogueira RG, Gupta R, Dávalos A. IMS-III and SYNTHESIS Expansion Trials of Endovascular Therapy in Acute Ischemic Stroke: How Can We Improve? Stroke 2013; 44: 3272-4.
75. Jauch EC, Saver JL, Adams HP Jr, et al, Council on Peripheral Vascular Disease; Council on Clinical Cardiology. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013; 44: 870-947.
76. Molina CA, Chamorro A, Rovira A, et al. REVASCAT: a randomized trial of revascularization with SOLITAIRE FR® device vs. best medical therapy in the treatment of acute stroke due to anterior circulation large vessel occlusion presenting within eight-hours of symptom onset. Int J Stroke. 2013 Nov 10. doi: 10. 1111/ijs. 12157. [Epub ahead of print].